ADAR1 Capital Management »

Guardant Health shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Guardant Health (GH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Guardant Health

Tip: Access up to 7 years of quarterly data

All positions including Guardant Health held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardant Health by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $982k 34k 28.88
2024-03-31 $2.4M 117k 20.63

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Guardant Health

Vanguard Group
BlackRock
Wellington Management Company
Cadian Capital Management
Deep Track Capital
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Eventide Asset Management
Ubs Global Asset Management Americas
Braidwell
Invesco
Geode Capital Management
Parkwood
State Street Corporation
Hanna Zanoni

View all funds holding Guardant Health